Vancomycin Cerebrospinal Fluid Pharmacokinetics in Children with Cerebral Ventricular Shunt Infections
Julie Autmizguine, Kevin Watt(University of Utah), Cassie Moran(Duke University), Edmund V. Capparelli(University of California San Diego), Daniel González(University of North Carolina at Chapel Hill), Daniel K. Benjamin(Duke University), Gerald A. Grant(Duke University), P. Brian Smith(Duke University), Michael Cohen‐Wolkowiez(Duke University)
Cited by 9
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial*
|Critical Care Medicine|2017|469
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337